PHARMACOLOGICAL INHIBITION OF TFF3 ENHANCES SENSITIVITY-AND OVERCOMES ACQUIRED RESISTANCE-TO DOXORUBICIN IN ESTROGEN RECEPTOR-POSITIVE BREAST CANCER
Ph.D
Saved in:
Main Author: | POH HAN MING |
---|---|
Other Authors: | PHARMACOLOGY |
Format: | Theses and Dissertations |
Language: | English |
Published: |
2020
|
Subjects: | |
Online Access: | https://scholarbank.nus.edu.sg/handle/10635/170803 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Institution: | National University of Singapore |
Language: | English |
Similar Items
-
Inhibition of TFF3 enhances sensitivity—and overcomes acquired resistance—to doxorubicin in estrogen receptor-positive mammary carcinoma
by: Poh, H.M., et al.
Published: (2021) -
The role of TFF3 in cytotoxic drug resistance of breast cancer
by: ZHANG WANQIU
Published: (2014) -
Body fat composition impacts the hematologic toxicities and pharmacokinetics of doxorubicin in Asian breast cancer patients
by: Wong, A.L., et al.
Published: (2014) -
The in vitro cytotoxicity and in vivo toxicity of doxorubicin antiresistant stealth liposomes
by: Wang, J.-C., et al.
Published: (2014) -
Pharmacogenetics of Doxorubicin in Asian Breast Cancer Patients
by: SUMAN LAL CHIRAMMAL SUGUNAN
Published: (2011)